• OPEN AN ACCOUNT
Indian Indices
Sensex
74,781.76 -120.83
( -0.16%)
Global Indices
Nasdaq
52,596.82 511.72
(0.98%)
Dow Jones
7,678.62 65.92
(0.87%)
Hang Seng
63,517.44 -493.90
(-0.77%)
Nikkei 225
10,692.77 42.33
(0.40%)
Forex
USD-INR
95.45 0.39
(0.41%)
EUR-INR
110.95 0.35
(0.32%)
GBP-INR
129.16 0.36
(0.28%)
JPY-INR
0.62 0.00
(0.09%)

EQUITY - MARKET SCREENER

CreditAccess Grameen Ltd
Industry :  Finance & Investments
BSE Code
ISIN Demat
Book Value()
541770
INE741K01010
488.6767868
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
CREDITACC
18.91
22901.14
EPS(TTM)
Face Value()
Div & Yield %
75.45
10
0
 

adroit infotech ltd
JFL Life Sciences standalone net profit rises 1975.00% in the March 2026 quarter
May 30,2026
Net profit of JFL Life Sciences rose 1975.00% to Rs 1.66 crore in the quarter ended March 2026 as against Rs 0.08 crore during the previous quarter ended March 2025. Sales rose 437.51% to Rs 63.05 crore in the quarter ended March 2026 as against Rs 11.73 crore during the previous quarter ended March 2025.

For the full year,net profit rose 53.85% to Rs 6.40 crore in the year ended March 2026 as against Rs 4.16 crore during the previous year ended March 2025. Sales rose 60.14% to Rs 131.38 crore in the year ended March 2026 as against Rs 82.04 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales63.0511.73 438 131.3882.04 60
OPM %5.5711.68 -8.9210.00 -
PBDT2.521.04 142 9.687.13 36
PBT2.250.68 231 8.606.14 40
NP1.660.08 1975 6.404.16 54